GAMINI S SOORIYAARACHCHI M.D. NPI 1891775789

NPI Details

Gamini S Sooriyaarachchi, M.D. is a medical oncology internal medicine in Cape Coral, FL with 56 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Gamini S Sooriyaarachchi, M.D. NPI is 1891775789. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1708 CAPE CORAL PKWY W STE 10
CAPE CORAL, FL
ZIP 33914-985
Phone: (239) 541-4633
Fax: (239) 541-1825

The NPI 1891775789 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, romiplostim, 10 micrograms (HCPCS:J2796)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Ferritin (blood protein) level (HCPCS:82728)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Iron level (HCPCS:83540)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Iron binding capacity (HCPCS:83550)
• Protein measurement, serum (HCPCS:84165)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Folic acid level, serum (HCPCS:82746)
• Magnesium level (HCPCS:83735)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection of drug or substance into vein (HCPCS:96374)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Drawing of blood for a medical problem (HCPCS:99195)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Uric acid level, blood (HCPCS:84550)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Automated urinalysis test (HCPCS:81003)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Homocysteine (amino acid) level (HCPCS:83090)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood test, clotting time (HCPCS:85610)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Red blood count, manual test (HCPCS:85044)
• Erythropoietin (protein) level (HCPCS:82668)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Urinalysis, manual test (HCPCS:81002)
• Red blood count, automated test (HCPCS:85045)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)

The enumeration date for this NPI number is 1/18/2006 and was last updated on 9/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.